Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 3 of the 13 calendar months from Oct 2025 to Oct 2026: Oct 2025, Apr 2026 and May 2026.
- Largest single sale: $12.7M (243,596 shares) of Kiniksa Pharmaceuticals International, plc on Apr 28, 2026. Filing
- Last sale before this period: May 28, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, plc (KNSA) | Chairman & CEO, Director | May 23, 2018 | Sep 3, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 1, 2026, Kiniksa Pharmaceuticals International, plc: 62,636 shares vested; 30,288 shares withheld by the company for taxes (some held indirectly). 2 filings: 1, 2
- Jun 1, 2026, Kiniksa Pharmaceuticals International, plc: 1,800,000 shares converted (some held indirectly). 1 filing: 1
- May 1, 2026, Kiniksa Pharmaceuticals International, plc: sold 48,565 shares for $2.6M, under a disclosed plan; 48,565 shares vested or acquired by exercising options. 1 filing: 1
- Apr 30, 2026, Kiniksa Pharmaceuticals International, plc: sold 2,141 shares for $116K, under a disclosed plan; 2,141 shares vested or acquired by exercising options. 1 filing: 1
- Apr 29, 2026, Kiniksa Pharmaceuticals International, plc: sold 22,544 shares for $1.2M, under a disclosed plan; 22,544 shares vested or acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.